OR WAIT null SECS
October 01, 2011
As editor of Pharmaceutical Technology Europe, I often have the opportunity to visit the sites of a wide variety of companies within the industry. Though differing vastly in the technologies and staff they employ, they all share one thing in common for me: the "you learn something new every day!" factor.
September 02, 2011
Being aware of a forthcoming inspection or how a product was made can make a huge difference.
A report commissioned by FDA evaluates the QbD program.
After a series of structural changes, the author wonders whether USP is undergoing an identity crisis. USP CEO Roger L. Williams responds.
August 02, 2011
Are biosimilars the next big thing or just the next big bubble?
Visiting a new site or going down memory lane may not get you where you want to go.
New studies reveal the promise and feasibility of transdermal vaccine delivery.
Quality management requires more effort in a complex supply chain.
August 01, 2011
Supplier differentiation is increasingly important in the highly competitive arena of pharmaceutical outsourcing.
Croatia is on track to join the EU in 2013 and offers a well-developed pharmaceutical market. However, its EU membership application has undergone much scrutiny.